van der Weerd, Neelke C <br/><br/>
Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents.  [electronic resource] 

 -  PloS one  2012 
 - e39783 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0039783  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antimicrobial Cationic Peptides--blood<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>Cross-Sectional Studies<br/>Erythropoiesis--drug effects<br/>Erythropoietin--blood<br/>Female<br/>Ferritins--blood<br/>Glomerular Filtration Rate--drug effects<br/>Hematinics--therapeutic use<br/>Hepcidins<br/>Humans<br/>Iron--metabolism<br/>Kidney--drug effects<br/>Kidney Failure, Chronic--blood<br/>Male<br/>Middle Aged<br/>Peptide Fragments--blood<br/>Renal Dialysis